\-\ Texto\\:\\ \ \(0\)\
\-\ axial\\ ct\\â\\€\\™s\\ of\\ the\\ head\\ without\\ contrast\\ demonstrate\\ 2\\ focal\\ areas\\ of\\ hyperdensity\\ with\\ a\\ central\\ and\\ surrounding\\ hypodensity\\.\\ \\ a\\ significant\\ midline\\ shift\\ is\\ evident\\ with\\ effacement\\ of\\ the\\ right\\ lateral\\ ventricle\\ and\\ entrapment\\ of\\ the\\ left\\ lateral\\ ventricle\\.\\ \\ \\ \ \(0\)\
\-\ axial\\ t1\\ pg\\ images\\ show\\ the\\ lesions\\ to\\ be\\ hyperintense\\,\\ and\\ well\\ defined\\,\\ with\\ a\\ surrounding\\ hypointensity\\.\\ \\ \\ again\\,\\ significant\\ mass\\ effect\\ is\\ noted\\.\\ \\ \ \(0\)\
\-\ axial\\ t2\\ fse\\ images\\ demonstrate\\ the\\ lesions\\ to\\ be\\ iso\\-\\ to\\ hypointense\\,\\ with\\ marked\\ surrounding\\ hyperintensities\\ that\\ is\\ similar\\ in\\ intensity\\ to\\ csf\\.\ \(0\)\
\-\ primary\\ cns\\ lymphoma\ \(0\)\
\-\ toxoplasmosis\ \(14\)\
\-\ metastasis\ \(206\)\
\-\ malignant\\ glioma\ \(1\)\
\-\ 22\\ y\\/o\\ healthy\\ male\\ with\\ confusion\\ and\\ lethargy\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ surrounding\\:\\ 0\\.27585196633014436\ \(0\)\
\-\ axial\\:\\ 0\\.23891938762073062\ \(0\)\
\-\ ventricle\\:\\ 0\\.20297090196965323\ \(0\)\
\-\ hyperdensity\\:\\ 0\\.1752466314823149\ \(0\)\
\-\ hyperintensities\\:\\ 0\\.1687628096799129\ \(0\)\
\-\ fse\\:\\ 0\\.16042816777828692\ \(0\)\
\-\ significant\\:\\ 0\\.15920845249273766\ \(0\)\
\-\ lesions\\:\\ 0\\.1583628487492696\ \(0\)\
\-\ pg\\:\\ 0\\.15758140394600328\ \(0\)\
\-\ toxoplasmosis\\:\\ 0\\.15503488692295356\ \(0\)\
\-\ hypointensity\\:\\ 0\\.15424237142053607\ \(0\)\
\-\ lethargy\\:\\ 0\\.15347501943660768\ \(0\)\
\-\ hypodensity\\:\\ 0\\.14996603452702095\ \(0\)\
\-\ entrapment\\:\\ 0\\.1493214748003946\ \(0\)\
\-\ confusion\\:\\ 0\\.14748492906575178\ \(0\)\
\-\ demonstrate\\:\\ 0\\.1433516099087386\ \(0\)\
\-\ to\\:\\ 0\\.1378708658606677\ \(0\)\
\-\ the\\:\\ 0\\.13755224799804322\ \(0\)\
\-\ lateral\\:\\ 0\\.1368456410249185\ \(0\)\
\-\ effacement\\:\\ 0\\.13672195892096553\ \(0\)\
\-\ with\\:\\ 0\\.13498525648717954\ \(0\)\
\-\ cns\\:\\ 0\\.1287519679626714\ \(0\)\
\-\ images\\:\\ 0\\.12754991105007912\ \(0\)\
\-\ again\\:\\ 0\\.12298145112996733\ \(0\)\
\-\ hypointense\\:\\ 0\\.12132818750130543\ \(0\)\
\-\ shift\\:\\ 0\\.12112925998060688\ \(0\)\
\-\ evident\\:\\ 0\\.11850362813298647\ \(0\)\
\-\ glioma\\:\\ 0\\.11712213457303979\ \(0\)\
\-\ healthy\\:\\ 0\\.1169548705329891\ \(0\)\
\-\ and\\:\\ 0\\.11395820132581261\ \(0\)\
\-\ is\\:\\ 0\\.11327150993194296\ \(0\)\
\-\ be\\:\\ 0\\.1118582758981736\ \(0\)\
\-\ hyperintense\\:\\ 0\\.10967062718730038\ \(0\)\
\-\ csf\\:\\ 0\\.10894184160269205\ \(0\)\
\-\ 22\\:\\ 0\\.10858552717913414\ \(0\)\
\-\ of\\:\\ 0\\.10792372079228706\ \(0\)\
\-\ similar\\:\\ 0\\.10507972897366248\ \(0\)\
\-\ marked\\:\\ 0\\.10427734633196702\ \(0\)\
\-\ midline\\:\\ 0\\.1036925704524041\ \(0\)\
\-\ metastasis\\:\\ 0\\.10104995168315746\ \(0\)\
\-\ defined\\:\\ 0\\.09835713459634236\ \(0\)\
\-\ malignant\\:\\ 0\\.09828003865433603\ \(0\)\
\-\ intensity\\:\\ 0\\.09789820516285029\ \(0\)\
\-\ effect\\:\\ 0\\.09671536082717905\ \(0\)\
\-\ areas\\:\\ 0\\.09360549184297774\ \(0\)\
\-\ central\\:\\ 0\\.09206942500584775\ \(0\)\
\-\ show\\:\\ 0\\.08752428581632488\ \(0\)\
\-\ t1\\:\\ 0\\.08590283980666784\ \(0\)\
\-\ primary\\:\\ 0\\.08477637511703896\ \(0\)\
\-\ focal\\:\\ 0\\.0824687683489102\ \(0\)\
\-\ head\\:\\ 0\\.08222985809398924\ \(0\)\
\-\ lymphoma\\:\\ 0\\.08211128275889709\ \(0\)\
\-\ t2\\:\\ 0\\.07932153814282954\ \(0\)\
\-\ noted\\:\\ 0\\.07309950556041166\ \(0\)\
\-\ without\\:\\ 0\\.07272226958304091\ \(0\)\
\-\ contrast\\:\\ 0\\.06698916510051704\ \(0\)\
\-\ well\\:\\ 0\\.06675827743016799\ \(0\)\
\-\ male\\:\\ 0\\.061385895458389766\ \(0\)\
\-\ that\\:\\ 0\\.059831255517717036\ \(0\)\
\-\ mass\\:\\ 0\\.05266340405167876\ \(0\)\
\-\ ct\\:\\ 0\\.052489145493470286\ \(0\)\
\-\ left\\:\\ 0\\.0470311288422989\ \(0\)\
\-\ right\\:\\ 0\\.04571025570999952\ \(0\)\
\-\ in\\:\\ 0\\.03429806643611047\ \(0\)\
